Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$127.77

1.77 (1.40%)

05:18
07/13/18
07/13
05:18
07/13/18
05:18

Technical Take: Johnson & Johnson slides after $4.69B verdict against company

In pre-market trading the shares are not far from the post-verdict price reaction last night after the bell. At the current price of $125.49, the shares are down over 1.77% on the day. Support is at $124.31. Resistance is at the prior-session closing price of $127.76.

  • 17

    Jul

JNJ Johnson & Johnson
$127.77

1.77 (1.40%)

07/06/18
RBCM
07/06/18
NO CHANGE
Target $143
RBCM
Outperform
Johnson & Johnson price target lowered to $143 from $155 at RBC Capital
RBC Capital analyst Glenn Novarro lowered his price target on Johnson & Johnson to $143 ahead of its Q2 results, saying the trends in the U.S. prescription drug market suggest that any upside in the company's Pharmaceutical segment is unlikely. Novarro expects the management to affirm its FY18 guidance for operational growth and earnings, but warns that the revenue guidance may see a downgrade due to the recent USD strength. The analyst also lowered his FY18 revenue projections to $81.1B from $81.3B and FY19 forecast to $80.6B from $83.0B.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/12/18
GSCO
07/12/18
UPGRADE
GSCO
Neutral
Johnson & Johnson upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jami Rubin upgraded Johnson & Johnson (JNJ) to Neutral with an unchanged price target of $134. The shares closed yesterday down $1.11 to $126.24. The stock is down 10% year-to-date and 15% from its recent all-time high of $148, Rubin tells investors in a research note. She notes J&J is trading in line with the large cap Pharmaceuticals group at 15 times 2019 estimates. The company's non-operational earnings revisions are now better understood by investors at current share levels, Rubin contends. The analyst this morning also downgraded Perrigo (PRGO) to Sell from Neutral.
07/12/18
07/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the stock is down 10% year-to-date and 15% from its recent all-time high of $148. 2. Hallmark Financial (HALL) upgraded to Outperform from Market Perform at Raymond James. 3. Transocean (RIG), Ensco (ESV), and Rowan Companies (RDC) were upgraded to Buy from Hold at Tudor Pickering. 4. Precision Drilling (PDS) and Nabors Industries (NBR) were upgraded to Overweight from Equal Weight at Morgan Stanley. 5. CA Technologies (CA) upgraded to Market Perform from Underperform at Wells Fargo and Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ABT

Abbott

$68.72

-0.62 (-0.89%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Initiation
Abbott initiated  »

Abbott initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SBBX

SB One Bancorp

$24.00

-0.27 (-1.11%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Hot Stocks
Breaking Hot Stocks news story on SB One Bancorp »

EJF Capital reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$30.64

0.42 (1.39%)

17:04
10/15/18
10/15
17:04
10/15/18
17:04
Earnings
CryoLife reports preliminary Q3 revenue $64.6M, consensus $61.84M »

Preliminary and unaudited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

, RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:03
10/15/18
10/15
17:03
10/15/18
17:03
Hot Stocks
Turquoise Hill provides underground development update »

Turquoise Hill (TRQ)…

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

RIO

Rio Tinto

$49.54

0.34 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:02
10/15/18
10/15
17:02
10/15/18
17:02
Earnings
Palo Alto Networks backs Q1 EPS view $1.04-$1.06, consensus $1.06 »

Backs Q1 revenue view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Turquoise Hil reports Q3 throughput down 5% y/y »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Hanwah Q Cells »

Hanwha Q CELLS trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:00
10/15/18
10/15
17:00
10/15/18
17:00
Hot Stocks
Palo Alto Networks names Amit Singh as President »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

BCOR

Blucora

$32.96

-0.23 (-0.69%)

16:59
10/15/18
10/15
16:59
10/15/18
16:59
Hot Stocks
Blucora names Tran Taylor chief HR officer »

Blucora announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

16:56
10/15/18
10/15
16:56
10/15/18
16:56
Periodicals
Facebook to ban false information on voting ahead of midterms, Reuters says »

Facebook plans to ban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

ADBE

Adobe

$238.05

-10.84 (-4.36%)

16:55
10/15/18
10/15
16:55
10/15/18
16:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

LDOS

Leidos

$66.00

0.91 (1.40%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Hot Stocks
Leidos achieves CMMI Level 3 for Development »

Leidos announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AGN

Allergan

$183.03

-0.275 (-0.15%)

, ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Conference/Events
Aclaris Therapeutics to host conference call »

Conference call to…

AGN

Allergan

$183.03

-0.275 (-0.15%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 30

    Oct

  • 27

    Nov

SEND

SendGrid

$30.94

0.04 (0.13%)

16:47
10/15/18
10/15
16:47
10/15/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SendGrid »

SendGrid spikes up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Twilio to acquire SendGrid for $2B or $36.92 per share in all-stock deal »

Twilio (TWLO) and…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Hanwah Q Cells to be acquired by Hanwha Solar for ~ $825M equity value »

Hanwha Q CELLS announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Tallgrass Energy increases quarterly dividend 2.5% »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAGE

WageWorks

$41.55

0.42 (1.02%)

16:42
10/15/18
10/15
16:42
10/15/18
16:42
Hot Stocks
WageWorks appoints Ismail Dawood as CFO »

The board of WageWorks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$14.80

-0.05 (-0.34%)

16:37
10/15/18
10/15
16:37
10/15/18
16:37
Hot Stocks
Cott Corp. subsidiary acquires Mountain Valley for $78.5M »

Cott Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

EBS

Emergent BioSolutions

$60.47

-0.4 (-0.66%)

16:36
10/15/18
10/15
16:36
10/15/18
16:36
Hot Stocks
Emergent BioSolutions completes Adapt Pharma acquisition »

Emergent BioSolutions …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EIGR

Eiger BioPharmaceuticals

$10.25

0.05 (0.49%)

16:35
10/15/18
10/15
16:35
10/15/18
16:35
Hot Stocks
Breaking Hot Stocks news story on Eiger BioPharmaceuticals »

683 Capital reports 5.9%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

RPD

Rapid7

$33.33

-0.59 (-1.74%)

16:33
10/15/18
10/15
16:33
10/15/18
16:33
Hot Stocks
Rapid7 acquires tCell.io, terms not disclosed »

Rapid7, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

  • 13

    Nov

KALU

Kaiser Aluminum

$102.46

1.04 (1.03%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32
Hot Stocks
Kaiser Aluminum authorizes additional $100M for share repurchases »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.